Yu et al identified tumor size, pleural invasion, and carcinoembryonic antigen (CEA) levels as independent risk factors for LNM, highlighting the need for these markers to be considered when planning treatment strategies[5]. The gene discussed is CEACAM5; the disease is neoplasm.